Dashboard
Manage Tickers

CDXS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 12:08:55

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 21:06:15

codexis-q2-eps-016-beats-019-estimate-sales-1533m-beat-1411m-estimate
Codexis Q2 EPS $(0.16) Beats $(0.19) Estim...
08/13/2025 20:07:22

Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 12:08:29

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

a-look-at-codexiss-upcoming-earnings-report
A Look at Codexis's Upcoming Earnings Report
08/12/2025 21:01:15

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/10/2025 21:05:48

codexis-presents-data-at-tides-usa-showcasing-proprietary-eco-synthesis-platforms-ability-to-support-sirna-manufacturing-by-reducing-purification-costs-improving-process-performance-and-demonstrating-potential-to-control-stereochemistry
Codexis Presents Data At TIDES USA Showcas...
05/22/2025 11:10:54

Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/14/2025 21:05:46

codexis-affirms-fy2025-sales-guidance-of-6400m-6800m-vs-6567m-est
Codexis Affirms FY2025 Sales Guidance of $...
05/14/2025 20:07:13

Codexis (NASDAQ:CDXS) affirms FY2025 sales outlook from $64.00 million-$68.00 million to $64.00 million-$68.00 million vs $65.6...

codexis-q1-eps-025-misses-023-estimate-sales-754m-miss-966m-estimate
Codexis Q1 EPS $(0.25) Misses $(0.23) Esti...
05/14/2025 20:06:25

Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by ...

Core News & Articles
Earnings Scheduled For May 14, 2025
05/14/2025 08:32:23

preview-codexiss-earnings
Preview: Codexis's Earnings
05/13/2025 21:03:14

codexis-secures-first-revenue-deal-for-eco-synthesis-marks-milestone-in-enzymatic-sirna-manufacturing
Codexis Secures First Revenue Deal For ECO...
03/24/2025 11:21:18

Represents first project to enter the ECO Synthesis™ Innovation LabCore enzymes for ECO Synthesis™ technology have transitioned...

codexis-sees-fy2025-sales-64000m-68000m-vs-6661m-est
Codexis Sees FY2025 Sales $64.000M-$68.000...
02/27/2025 21:24:43

Codexis (NASDAQ:CDXS) sees FY2025 sales of $64.000 million-$68.000 million vs $66.61 million analyst estimate.

codexis-q4-eps-013-misses-004-estimate-sales-2146m-miss-2741m-estimate
Codexis Q4 EPS $(0.13) Misses $(0.04) Esti...
02/27/2025 21:23:48

Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.04) by ...

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

deep-dive-into-codexis-stock-analyst-perspectives-4-ratings
Deep Dive Into Codexis Stock: Analyst Pers...
11/22/2024 15:00:47

cantor-fitzgerald-reiterates-overweight-on-codexis-maintains-11-price-target
Cantor Fitzgerald Reiterates Overweight on...
11/22/2024 14:26:23

Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:CDXS) with a Overweight and maintains $11 price target.

cantor-fitzgerald-reiterates-overweight-on-codexis-maintains-11-price-target
Cantor Fitzgerald Reiterates Overweight on...
11/15/2024 14:38:53

Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:CDXS) with a Overweight and maintains $11 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION